<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>大叔快评 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-28T01:53:42+08:00</updated>
  <subtitle>肿瘤学临床研究及制药企业研发评述</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2021年快到了，立个flag吧</title>
    <updated>2020-12-28T00:05:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-28:/s/Vsu4bm9dQWpjWbwbZNxYWw</id>
    <link href="https://mp.weixin.qq.com/s/Vsu4bm9dQWpjWbwbZNxYWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>血友病A患者根据药代动力学预防治疗的临床观察结果</title>
    <updated>2020-12-24T22:09:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/cEdIr8zC98g8vvNmvz8nog</id>
    <link href="https://mp.weixin.qq.com/s/cEdIr8zC98g8vvNmvz8nog" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>波齐替尼Poziotinib谋求上市和新给药剂量方案</title>
    <updated>2020-12-24T22:09:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/ZNBGnmbwkYDtwmYxSyNzFw</id>
    <link href="https://mp.weixin.qq.com/s/ZNBGnmbwkYDtwmYxSyNzFw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥希替尼说明书2020年12月更新内容</title>
    <updated>2020-12-24T22:09:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-24:/s/tZJcGf8gsXyzbKqI--OzJQ</id>
    <link href="https://mp.weixin.qq.com/s/tZJcGf8gsXyzbKqI--OzJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>看清“势”的底色</title>
    <updated>2020-12-22T21:37:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/5niTqMBUj_0cJba-XlDZ3g</id>
    <link href="https://mp.weixin.qq.com/s/5niTqMBUj_0cJba-XlDZ3g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田中国与丁香园签订战略合作协议，共探医药数字化营销生态范式</title>
    <updated>2020-12-22T21:37:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-22:/s/ooL3O3GaZg5KwniN9k-Hzg</id>
    <link href="https://mp.weixin.qq.com/s/ooL3O3GaZg5KwniN9k-Hzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>确定了，医学联络官也需备案管理</title>
    <updated>2020-12-21T16:52:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/q78HUP5M6d1bQKPX1BrkQg</id>
    <link href="https://mp.weixin.qq.com/s/q78HUP5M6d1bQKPX1BrkQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CD30学院 | 宋玉琴教授——外周T细胞淋巴瘤治疗新进展</title>
    <updated>2020-12-21T16:52:30+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/PW5404a6zaalzJd8SHOvEg</id>
    <link href="https://mp.weixin.qq.com/s/PW5404a6zaalzJd8SHOvEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准口服relugolix用于治疗晚期前列腺癌</title>
    <updated>2020-12-19T21:48:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/Q_mHm0m0iiqh7XYbOwx2cA</id>
    <link href="https://mp.weixin.qq.com/s/Q_mHm0m0iiqh7XYbOwx2cA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA批准武田ICLUSIG用于治疗CP-CML前序耐药或不耐受的成年患者</title>
    <updated>2020-12-19T21:48:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/aRxnsM8JD7JoEgwrFN7Nzw</id>
    <link href="https://mp.weixin.qq.com/s/aRxnsM8JD7JoEgwrFN7Nzw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【资讯】FDA批准Selinexor用于难治/复发性多发性骨髓瘤</title>
    <updated>2020-12-19T21:48:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/Flx-TmCjXccwr4LqW1k-DA</id>
    <link href="https://mp.weixin.qq.com/s/Flx-TmCjXccwr4LqW1k-DA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>奥希替尼获FDA批准用于NSCLC辅助治疗</title>
    <updated>2020-12-19T11:54:51+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/2M07wGQUIlLOzcrIA6uuFQ</id>
    <link href="https://mp.weixin.qq.com/s/2M07wGQUIlLOzcrIA6uuFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>就在刚刚，武田中国斩获两项荣誉</title>
    <updated>2020-12-18T21:16:29+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/ZxK72OCpmKHmyJlKsQOuFQ</id>
    <link href="https://mp.weixin.qq.com/s/ZxK72OCpmKHmyJlKsQOuFQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田在2020年美国血液学会年会（ASH）上发布真实世界证据</title>
    <updated>2020-12-17T21:30:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/4hFyylGx_UR4HKuZIFtHJA</id>
    <link href="https://mp.weixin.qq.com/s/4hFyylGx_UR4HKuZIFtHJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>NEJM: mRNA新冠疫苗安全性与有效性</title>
    <updated>2020-12-16T16:35:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/jqG8tRwR01B9kd-FpM1Gaw</id>
    <link href="https://mp.weixin.qq.com/s/jqG8tRwR01B9kd-FpM1Gaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>医学洞见(Insight)怎么写?</title>
    <updated>2020-12-16T16:35:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/-zVCNY2ZthKmX00GKx3Kww</id>
    <link href="https://mp.weixin.qq.com/s/-zVCNY2ZthKmX00GKx3Kww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MET异常NSCLC的基因异质性和免疫治疗的临床疗效</title>
    <updated>2020-12-16T16:35:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/46kOF3W0BDF2qf0ljQKHhw</id>
    <link href="https://mp.weixin.qq.com/s/46kOF3W0BDF2qf0ljQKHhw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>李建勇教授点评 | 复发难治霍奇金淋巴瘤合并自身免疫性疾病中CD30单抗的应用一例</title>
    <updated>2020-12-15T22:33:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/ljLBltsbvaE7KGHmZLYNug</id>
    <link href="https://mp.weixin.qq.com/s/ljLBltsbvaE7KGHmZLYNug" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>